from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3299c/atsB

LFCtreatmentdescriptionclass of inhibitor

1.174

Amikacinug/mL Amikacintranslation

-0.479

Cap5-10ug/mL Capreomycintranslation

-0.691

Rox10-50 ug/mL Roxithromycintranslation

0.090

SM2-5 ug/mL Streptomycintranslation

-1.120

Tet5-10 ug/mL Tetracyclinetranslation

0.859

Rif0.2-5ug/mL Rifampicintranscription

-0.034

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.618

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.111

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.031

CPZ10-50 ug/mL Chlorpromazinerespiration

0.191

Clofazimine10-13 ug/mL Clofaziminerespiration

0.042

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.810

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.193

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.369

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.195

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.014

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.119

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.509

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.016

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.878

KCN5-20 ug/mL Potassium cyaniderespiration

0.285

NaN30.2-2 mM Sodium aziderespiration

0.265

Nigericin50 uM Nigericinrespiration

0.096

TRC10-150 ug/mL Triclosanrespiration

1.329

TRZ10-25 ug/mL Thioridazinerespiration

-1.854

Valinomycin0.5-10 uM Valinomycinrespiration

0.160

ZnSO42 mM ZnSO4respiration

0.312

menadione6-10 ug/mL Menadionerespiration

0.295

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.031

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.199

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.502

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.673

NRP_1Non-replicating persistence stage 1dosRassociated

-0.138

Amp0.2mg/mL AmpicillincellWall

0.670

Cephalexin20-100 ug/mL CephalexincellWall

-0.178

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.451

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.281

EMB10-20 ug/mL EthambutolcellWall

0.359

Eta12-40 ug/mL EthionamidecellWall

0.704

INH0.2-0.4 ug/mL IsoniazidcellWall

0.167

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.465

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.932

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.126

BZA0.12 mg/mL BenzamidearomaticAmides

-0.159

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.079

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.823

H2O24 mM hydrogen peroxideDNAdamaging

-0.553

Levo10 ug/mL LevofloxacinDNAdamaging

-1.150

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.276

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.206

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.884

UVUV-irradiationDNAdamaging

1.505

ARP41-4 ug/mL Antitubercular compound ARP4?

0.063

Antimycin12.5-50 ug/mL Antimycin A?

-0.160

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.516

PA_110-50 ug/mL Antitubercular compound PA-1?

0.308

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.544

PA8240.2-2 ug/mL PA-824?

0.659

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.168

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.218

Verapamil50 uM Verapamil?

0.108

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.911

methoxatin10-20 ug/mL Methoxatin?